Growth Equity

Redesign Health launches Growth Equity arm for Series A to pre-IPO

NEW YORK — November 13, 2026 -- Redesign Health has launched a dedicated Growth Equity practice that will make minority investments in healthcare companies from Series A through pre-IPO, adding a third strategy to its seed and venture buyout activities. The New York-based firm has invested since its founding in 2018, so the formal practice comes eight years into that activity, by FairsOnline's calculation.

Growth Equity targets healthcare IT, AI-enabled services and clinical AI

The practice focuses on businesses that already have customers, revenue and product-market fit. That separates it from the seed strategy, which backs founders at the earliest stages, and from the venture buyout strategy, which takes control positions in established businesses and applies AI to their operations.